FASN, fatty acid synthase, 2194

N. diseases: 245; N. variants: 6
Disease: Anorexia ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003123
Disease: Anorexia
Anorexia 		0.020 Biomarker disease BEFREE However, the clinical use of FASN inhibitors, such as cerulenin, C75, and epigallocatechin 3-gallate (EGCG), is limited by anorexia and induced body weight loss or by its low in vivo potency and stability. 20973802 2010
CUI: C0003123
Disease: Anorexia
Anorexia 		0.020 Biomarker disease BEFREE The use of FASN inhibitors has been limited until now by anorexia and weight loss, which is associated with the stimulation of fatty acid oxidation. 19189648 2009